Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cytokines, Cellular & Molecular Therapy|April 29, 1998
IL-1 receptor antagonist gene polymorphism in patients with secondary acute myeloid leukaemiaS E Langabeer, D C Linch
Experimental Oncology|July 17, 2025
ATYPICAL BRAF MUTATIONS IN HAIRY CELL LEUKEMIA: DIAGNOSTIC AND THERAPEUTIC CONSIDERATIONSS E Langabeer, G Crotty, C L Bacon
Irish Journal of Medical Science|April 19, 2007
Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disordersS E Langabeer, F Ni Ainle, E Conneally, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 2, 2017
Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisisS E Langabeer, K Haslam, J Kelly, et al.
Leukemia|March 16, 2002
Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemiaS E Langabeer, R E Gale, R C Harvey, et al.
Irish Journal of Medical Science|August 31, 2010
Incidence and significance of FLT3-ITD and NPM1 mutations in patients with normal karyotype acute myeloid leukaemiaK Haslam, N Chadwick, J Kelly, et al.
British Journal of Haematology|March 1, 1997
Frequency of CBF beta/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. The MRC Adult Leukaemia Working PartyS E Langabeer, H Walker, R E Gale, et al.
British Journal of Haematology|June 3, 1998
A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research CouncilS E Langabeer, D Grimwade, H Walker, et al.
International Journal of Laboratory Hematology|February 9, 2012
Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotypeS E Langabeer, D O'Brien, S Liptrot, et al.
British Journal of Haematology|January 31, 1998
Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials. MRC Adult Leukaemia Working PartyS E Langabeer, H Walker, J R Rogers, et al.
Pageof 2